RNF43 Inactivation Enhances the B-RAF/MEK Signaling and Creates a Combinatory Therapeutic Target in Cancer Cells

Investigators found that RING finger 43 (RNF43)-mutated pancreatic cancer cells exhibited elevated B-RAF/MEK activity and were highly sensitive to MEK inhibitors.